PHARMACOKINETICS OF HALOPERIDOL

被引：118
|
作者：
FROEMMING, JS
LAM, YWF
JANN, MW
DAVIS, CM
机构：
[1] MERCER UNIV,SO SCH PHARM,DEPT PHARM PRACTICE,ATLANTA,GA
[2] UNIV TEXAS,HLTH SCI CTR,DIV CLIN PHARM,SAN ANTONIO,TX 78284
[3] UNIV TEXAS,COLL PHARM,AUSTIN,TX 78712
[4] UNIV TEXAS,INST MENTAL SCI INST,HOUSTON,TX 77025
来源：
CLINICAL PHARMACOKINETICS | 1989年 / 17卷 / 06期
关键词：
D O I：
10.2165/00003088-198917060-00004
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：396 / 423
页数：28
相关论文
共 50 条
  • [11] HALOPERIDOL PHARMACOKINETICS IN HEALTHY-VOLUNTEERS
    KUNKA, RL
    STILLER, RL
    PEREL, JM
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (11) : S112 - S112
  • [12] PHARMACOKINETICS AND EFFECTS OF HALOPERIDOL IN THE ISOLATED MOUSE
    ZETLER, G
    BAUMANN, GH
    PHARMACOLOGY, 1985, 31 (06) : 318 - 327
  • [13] PHARMACOKINETICS OF HALOPERIDOL (HL) AND REDUCED HALOPERIDOL (RHL) IN GUINEA-PIGS
    YOUNG, D
    EDDINGTON, ND
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (02) : 177 - 177
  • [14] HALOPERIDOL PHARMACOKINETICS IN HEALTHY-VOLUNTEERS
    KUNKA, RL
    PEREL, JM
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1989, 45 (06): : 1088 - 1096
  • [15] PHARMACOKINETICS OF HALOPERIDOL IN SCHIZOPHRENIC AND MANIC PATIENTS
    CHENG, YF
    PAALZOW, L
    BONDESSON, U
    EKBLOM, B
    ERIKSSON, K
    ERIKSSON, SO
    LINDBERG, A
    LINDSTROM, L
    ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1986, 59 : 107 - 107
  • [16] PHARMACOKINETICS OF HALOPERIDOL AND CLOZAPINE WITH PHARMACODYNAMIC CONSIDERATIONS
    CHENG, YF
    ACTA PHARMACEUTICA NORDICA, 1989, 1 (06): : 373 - 374
  • [17] PHARMACOKINETICS OF HALOPERIDOL-C-14 IN MAN
    ILETT, KF
    MACKIE, AE
    JELLETT, LB
    MADSEN, BW
    SOMERS, K
    HUGHES, IE
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1978, 5 (03) : 267 - 268
  • [18] THE INFLUENCE OF CIGARETTE-SMOKING ON HALOPERIDOL PHARMACOKINETICS
    MILLER, DD
    KELLY, MW
    PERRY, PJ
    CORYELL, WH
    BIOLOGICAL PSYCHIATRY, 1990, 28 (06) : 529 - 531
  • [19] PHARMACOKINETICS OF HALOPERIDOL AND REDUCED HALOPERIDOL IN CHINESE SCHIZOPHRENIC-PATIENTS AFTER INTRAVENOUS AND ORAL-ADMINISTRATION OF HALOPERIDOL
    CHANG, WH
    LAM, YWF
    JANN, MW
    CHEN, H
    PSYCHOPHARMACOLOGY, 1992, 106 (04) : 517 - 522
  • [20] PHARMACOLOGY, PHARMACOKINETICS AND CLINICAL DEVELOPMENT OF HALOPERIDOL DECANOATE
    GELDERS, YG
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1986, 1 : 1 - 11
12345